Human TRANCE/TNFSF11/RANK L Antibody, R&D Systems™

TRANCE/TNFSF11/RANK L

Immunohistochemistry 8-25 ug/mL, Neutralization 0.8-2.5 ug/mL

Monoclonal

Purified

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

CD254, CD254 antigen, ODF, OPGL, OPGLOPTB2, Osteoclast differentiation factor, Osteoprotegerin ligand, RANK L, RANKL, RANKLreceptor activator of nuclear factor kappa B ligand, Receptor activator of nuclear factor kappa-B ligand, sOdf, TNF-related activation-induced cytokine, TNFSF11, TRANCEODFhRANKL2, tumor necrosis factor (ligand) superfamily, member 11, tumor necrosis factor ligand superfamily member 11

TNFSF11

IgG2b

Protein A or G purified from ascites

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

70525

Immunohistochemistry, Neutralization

Unconjugated

Mouse

Human

O14788

8600

S. frugiperdainsect ovarian cell lineSf21-derived recombinant human TRANCE/TNFSF11/RANK L Gly136-Asp317 (Ala194Gly) Accession # O14788

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human TRANCE/TNFSF11/RANK L in direct ELISAs. No cross-reactivity with recombinant mouse TRANCE is observed.